<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1624">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02043600</url>
  </required_header>
  <id_info>
    <org_study_id>13-5560-BO</org_study_id>
    <nct_id>NCT02043600</nct_id>
  </id_info>
  <brief_title>Randomized-controlled Trial of Yoga for Ulcerative Colitis</brief_title>
  <official_title>Randomized-controlled Trial of Yoga for Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Deutsche Morbus Crohn / Colitis ulcerosa Vereinigung DCCV</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universität Duisburg-Essen</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized trial is to investigate the effects of a 12-week yoga
      intervention compared to self-care on quality of life, stress, psychological health, and
      physiological parameters in 102 patients with ulcerative colitis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Disease-specific quality of life</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inflammatory Bowel Disease Questionnaire (IBDQ)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-specific quality of life</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inflammatory Bowel Disease Questionnaire (IBDQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-specific quality of life</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inflammatory Bowel Disease Questionnaire (IBDQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-specific quality of life</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inflammatory Bowel Disease Questionnaire (IBDQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic quality of life</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>36-Item Short Form Health Survey (SF-36)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic quality of life</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>36-Item Short Form Health Survey (SF-36)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic quality of life</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>36-Item Short Form Health Survey (SF-36)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic quality of life</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>36-Item Short Form Health Survey (SF-36)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety/depression</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hospital Anxiety and Depresion Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety/depression</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hospital Anxiety and Depresion Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety/depression</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hospital Anxiety and Depresion Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety/depression</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hospital Anxiety and Depresion Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Scale (PSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Scale (PSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Scale (PSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Scale (PSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Questionnaire (PSQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Questionnaire (PSQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Questionnaire (PSQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective stress</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived Stress Questionnaire (PSQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive/negative affect</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Positive and Negative Affect Schedule (PANAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive/negative affect</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Positive and Negative Affect Schedule (PANAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive/negative affect</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Positive and Negative Affect Schedule (PANAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive/negative affect</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Positive and Negative Affect Schedule (PANAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body awareness</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Awareness Questionnaire (BAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body awareness</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Awareness Questionnaire (BAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body awareness</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Awareness Questionnaire (BAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body awareness</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Awareness Questionnaire (BAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body responsiveness</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Responsiveness Scale (BRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body responsiveness</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Responsiveness Scale (BRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body responsiveness</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Responsiveness Scale (BRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body responsiveness</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body Responsiveness Scale (BRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>General Self-Efficacy Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>General Self-Efficacy Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>General Self-Efficacy Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>General Self-Efficacy Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood sedimentation rate</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood sedimentation rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood sedimentation rate</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood sedimentation rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecal calprotectin</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Faecal calprotectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecal calprotectin</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Faecal calprotectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecal lactoferrin</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Faecal lactoferrin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecal lactoferrin</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Faecal lactoferrin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecel PMN-elastase</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Faecel PMN-elastase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecel PMN-elastase</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Faecel PMN-elastase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease activity</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clinical Activity Index (CAI-Rachmilewitz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease activity</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clinical Activity Index (CAI-Rachmilewitz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease activity</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clinical Activity Index (CAI-Rachmilewitz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease activity</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clinical Activity Index (CAI-Rachmilewitz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary cortisol level</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Salivary cortisol level - cortisol awakening response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Steroid sensitivity</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Steroid sensitivity (IC50)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Andrenergic sensitivity</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Andrenergic sensitivity (IC50)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholinergic sensitivity</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cholinergic sensitivity (IC50)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of patients with adverse events/serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of patients with adverse events/serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of patients with adverse events/serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of patients with adverse events/serious adverse events</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adherence</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Intervention adherence (number of sessions attended and home practice diary)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Colitis, Ulcerative</condition>
  <arm_group>
    <arm_group_label>Yoga</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Self-care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Yoga</intervention_name>
    <description>12-week Hatha Yoga intervention 90 minutes once a week</description>
    <arm_group_label>Yoga</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-care</intervention_name>
    <description>Self-care books are provided for self-directed use</description>
    <arm_group_label>Self-care</arm_group_label>
    <other_name>Self-care book</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ulcerative colitis (clinical, endoscopic and histological diagnosis)

          -  Disease duration at least 12 months

          -  Clinical remission for at least 4 weeks and less than 12 months

          -  CAI &lt; 5

          -  IBDQ &lt; 170

          -  Physical and mental ability to perform yoga

          -  No regular practice of yoga or Pilates in the previous 12 months

        Exclusion Criteria:

          -  Clinically active disease (CAI &gt; 4 Rachmilewitz)

          -  Complete resection of the colon

          -  Acute, infectious or chronic active ulcerative colitis

          -  Severe disease precluding yoga practice

          -  Malignancy with a disease-free survival &lt; 5 years except curatively treated basalioma
             of the skin

          -  Alcohol or drug abuse

          -  Dementia

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holger Cramer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jost Langhorst, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Holger Cramer, PhD</last_name>
    <phone>+49 201 174-25054</phone>
    <email>h.cramer@kliniken-essen-mitte.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jost Langhorst, MD</last_name>
    <phone>+49 201 174-25012</phone>
    <email>j.langhorst@kliniken-essen-mitte.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen</name>
      <address>
        <city>Essen</city>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Cramer, PhD</last_name>
      <phone>+49 201 174-25054</phone>
      <email>h.cramer@kliniken-essen-mitte.de</email>
    </contact>
    <contact_backup>
      <last_name>Jost Langhorst, MD</last_name>
      <phone>+49 201 174-25012</phone>
      <email>j.langhorst@kliniken-essen-mitte.de</email>
    </contact_backup>
    <investigator>
      <last_name>Holger Cramer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 17, 2014</lastchanged_date>
  <firstreceived_date>January 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Holger Cramer</investigator_full_name>
    <investigator_title>Postdoctoral Researcher</investigator_title>
  </responsible_party>
  <keyword>Colitis, ulcerative</keyword>
  <keyword>Yoga</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
